Page last updated: 2024-10-23

benzbromarone and Diarrhea

benzbromarone has been researched along with Diarrhea in 2 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matzkies, F1
Bröll, H1
Sochor, H1
Tausch, G1
Eberl, R1

Other Studies

2 other studies available for benzbromarone and Diarrhea

ArticleYear
[Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Fortschritte der Medizin, 1978, Aug-24, Volume: 96, Issue:32

    Topics: Benzbromarone; Benzofurans; Diarrhea; Female; Gout; Humans; Kidney Calculi; Male; Nausea; Uric Acid

1978
[Long-term therapy with benzbromarone in uric arthritis].
    Wiener medizinische Wochenschrift (1946), 1975, Sep-19, Volume: 125, Issue:28

    Topics: Adult; Aged; Benzbromarone; Benzofurans; Diarrhea; Female; Gout; Humans; Leukopenia; Long-Term Care;

1975